| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Regular Articles |
Life Sciences Division, Lawrence Berkeley National Laboratory, Berkeley, California 94720 [C. W., S. S. G., C. L. C-L., A. K.], and Harvard Medical School, Boston, Massachusetts 02115 [W-C. L.]
Allelic loss is an important mutational mechanism in human carcinogenesis. Loss of heterozygosity (LOH) at an autosomal locus is one outcome of the repair of DNA double-strand breaks (DSBs) and can occur by deletion or by mitotic recombination. We report that mitotic recombination between homologous chromosomes occurred in human lymphoid cells exposed to densely ionizing radiation. We used cells derived from the same donor that express either normal TP53 (TK6 cells) or homozygous mutant TP53 (WTK1 cells) to assess the influence of TP53 on radiation-induced mutagenesis. Expression of mutant TP53 (Met 237 Ile) was associated with a small increase in mutation frequencies at the hemizygous HPRT (hypoxanthine phosphoribosyl transferase) locus, but the mutation spectra were unaffected at this locus. In contrast, WTK1 cells (mutant TP53) were 30-fold more susceptible than TK6 cells (wild-type TP53) to radiation-induced mutagenesis at the TK1 (thymidine kinase) locus. Gene dosage analysis combined with microsatellite marker analysis showed that the increase in TK1 mutagenesis in WTK1 cells could be attributed, in part, to mitotic recombination. The microsatellite marker analysis over a 64-cM region on chromosome 17q indicated that the recombinational events could initiate at different positions between the TK1 locus and the centromere. Virtually all of the recombinational LOH events extended beyond the TK1 locus to the most telomeric marker. In general, longer LOH tracts were observed in mutants from WTK1 cells than in mutants from TK6 cells. Taken together, the results demonstrate that the incidence of radiation-induced mutations is dependent on the genetic background of the cell at risk, on the locus examined, and on the mechanisms for mutation available at the locus of interest.
This article has been cited by other articles:
![]() |
C. N. Otis, P. A. Krebs, A. Albuquerque, M. M. Quezado, X. S. Juan, M. E. Sobel, and M. J. Merino Loss of Heterozygosity of p53, BRCA1, VHL, and Estrogen Receptor Genes in Breast Carcinoma: Correlation with Related Protein Products and Morphologic Features International Journal of Surgical Pathology, October 1, 2002; 10(4): 237 - 245. [Abstract] [PDF] |
||||
![]() |
U. Novak, E. Oppliger Leibundgut, J. Hager, D. Muhlematter, M. Jotterand, C. Besse, N. Leupin, D. Ratschiller, J. Papp, G. Kearsey, et al. A high-resolution allelotype of B-cell chronic lymphocytic leukemia (B-CLL) Blood, August 13, 2002; 100(5): 1787 - 1794. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Stopper and W. K. Lutz Induction of micronuclei in human cell lines and primary cells by combination treatment with {gamma}-radiation and ethyl methanesulfonate Mutagenesis, March 1, 2002; 17(2): 177 - 181. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Wiese, A. J. Pierce, S. S. Gauny, M. Jasin, and A. Kronenberg Gene Conversion Is Strongly Induced in Human Cells by Double-strand Breaks and Is Modulated by the Expression of BCL-xL Cancer Res., March 1, 2002; 62(5): 1279 - 1283. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Wiese, D. W. Collins, J. S. Albala, L. H. Thompson, A. Kronenberg, and D. Schild Interactions involving the Rad51 paralogs Rad51C and XRCC3 in human cells Nucleic Acids Res., February 15, 2002; 30(4): 1001 - 1008. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |